Patent ID: 6174876
Filing Date: 2001-01-16
Classification: A61K,A61P

Abstract:
A method of treating a patient having a brain tumor and a peritumoral brain edema, the method comprising administering to the patient a pharmaceutical composition comprising at least one component selected from the group consisting of pure boswellic acid, 11-keto-.beta.-boswellic acid, a lower alkyl ester of pure boswellic acid, a lower alkyl ester of 11-keto-.beta.-boswellic acid, wherein the ester is obtained by at least one of esterification of the carboxyl group with a C.sub.1 -C.sub.6 alcohol and by esterification of the hydroxyl group by a physiologically acceptable carboxylic acid, and a physiologically acceptable salt of any of them, the component being present in an amount effective to treat the brain tumor and treat the peritumoral brain edema.